Sight Sciences (SGHT) News Today $3.47 +0.11 (+3.27%) Closing price 04:00 PM EasternExtended Trading$3.47 0.00 (0.00%) As of 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGHT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Sight Sciences price target lowered to $4 from $4.50 at CitiOctober 7 at 3:19 PM | msn.comCitigroup Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $4.00October 7 at 2:06 PM | marketbeat.comAnalysts Set Sight Sciences, Inc. (NASDAQ:SGHT) Target Price at $4.42October 5 at 2:31 AM | americanbankingnews.comSight Sciences (NASDAQ:SGHT) CTO Sells $19,727.91 in StockOctober 4 at 6:49 AM | insidertrades.comDavid Badawi Sells 6,033 Shares of Sight Sciences (NASDAQ:SGHT) StockOctober 3, 2025 | marketbeat.comJeremy Hayden Sells 9,731 Shares of Sight Sciences (NASDAQ:SGHT) StockOctober 3, 2025 | marketbeat.comInsider Selling: Sight Sciences (NASDAQ:SGHT) CEO Sells 24,441 Shares of StockOctober 3, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Rating of "Hold" by AnalystsOctober 2, 2025 | marketbeat.comSight Sciences Amends Loan Agreement with HerculesSeptember 30, 2025 | tipranks.comPalumbo Wealth Management LLC Invests $328,000 in Sight Sciences, Inc. $SGHTSeptember 25, 2025 | marketbeat.comAcadian Asset Management LLC Purchases 242,559 Shares of Sight Sciences, Inc. $SGHTSeptember 18, 2025 | marketbeat.comSight Sciences announces publication of results on OMNI Surgical SystemSeptember 17, 2025 | msn.comSight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in ...September 17, 2025 | markets.businessinsider.comSight Sciences, Inc. Reports Positive Meta-Analysis Results for OMNI Surgical System in Treating Open-Angle GlaucomaSeptember 17, 2025 | quiverquant.comQSight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication UseSeptember 17, 2025 | globenewswire.com4,374,975 Shares in Sight Sciences, Inc. $SGHT Acquired by Kck Ltd.September 16, 2025 | marketbeat.comSight Sciences (NASDAQ:SGHT) Upgraded to "Hold" at Wall Street ZenSeptember 15, 2025 | marketbeat.comSight Sciences, Inc. (SGHT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 10, 2025 | seekingalpha.comSight Sciences, Inc.: Sight Sciences Announces the OMNI Surgical System to be Included in UnitedHealthcare's Expanded Coverage of Glaucoma Surgical TreatmentsSeptember 9, 2025 | finanznachrichten.deSight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical TreatmentsSeptember 9, 2025 | finance.yahoo.comSight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare's® Expanded Coverage of Glaucoma Surgical TreatmentsSeptember 9, 2025 | globenewswire.comSight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Hold" from AnalystsSeptember 8, 2025 | marketbeat.comSight Sciences (NASDAQ:SGHT) Downgraded to "Sell" Rating by Wall Street ZenSeptember 8, 2025 | marketbeat.comSight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJOSeptember 2, 2025 | globenewswire.comSight Sciences, Inc. $SGHT Shares Purchased by Long Focus Capital Management LLCSeptember 1, 2025 | marketbeat.comSight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare ConferenceAugust 26, 2025 | globenewswire.comWhat 4 Analyst Ratings Have To Say About Sight SciencesAugust 22, 2025 | benzinga.comSight Sciences price target raised to $4.50 from $3.60 at CitiAugust 21, 2025 | msn.comSight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of "Hold" by BrokeragesAugust 14, 2025 | marketbeat.comSight Sciences’ Earnings Call: Balancing Growth and ChallengesAugust 13, 2025 | msn.comLake Street Upgrades Sight Sciences (SGHT)August 11, 2025 | msn.comWall Street Zen Upgrades Sight Sciences (NASDAQ:SGHT) to HoldAugust 10, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Q2 2025 Earnings Call TranscriptAugust 9, 2025 | msn.comSight Sciences (NASDAQ:SGHT) Upgraded to Buy at Lake Street CapitalAugust 9, 2025 | marketbeat.comSight Sciences, Inc. (SGHT) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comSight Sciences Reports Q2 2025 Financial ResultsAugust 8, 2025 | tipranks.comSight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue GuidanceAugust 7, 2025 | globenewswire.comSight Sciences (SGHT) Projected to Post Earnings on ThursdayJuly 31, 2025 | marketbeat.comSight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye DiseaseJuly 30, 2025 | globenewswire.comSight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye DiseaseJuly 29, 2025 | globenewswire.comSight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025July 24, 2025 | globenewswire.comSight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Rating of "Hold" by BrokeragesJuly 19, 2025 | marketbeat.comWall Street Zen Downgrades Sight Sciences (NASDAQ:SGHT) to SellJuly 19, 2025 | marketbeat.com7SGHT : The Analyst Verdict: Sight Sciences In The Eyes Of 4...July 15, 2025 | benzinga.comSight Sciences (NASDAQ:SGHT) Given New $4.00 Price Target at Morgan StanleyJuly 15, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Insider Matthew Link Sells 4,889 SharesJuly 8, 2025 | insidertrades.comInsider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells 4,889 Shares of StockJuly 7, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) CTO Sells $23,681.43 in StockJuly 7, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $38,197.20 in StockJuly 7, 2025 | marketbeat.comInsider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CEO Sells 23,637 Shares of StockJuly 7, 2025 | marketbeat.com Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SGHT Media Mentions By Week SGHT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGHT News Sentiment▼0.310.55▲Average Medical News Sentiment SGHT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGHT Articles This Week▼133▲SGHT Articles Average Week Get the Latest News and Ratings for SGHT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Sight Sciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CLPT News SIBN News AVNS News ZIMV News BFLY News KIDS News TMCI News SMLR News CBLL News DCTH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGHT) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sight Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sight Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
